ERCROS INDUSTRIAL

Erythromycins

• Category :

  Pharmaceuticals and Biochemicals

• Synonyms :

  Erythromycin stearate [BAN:JAN];Abboticine;Bristamycin;CCRIS 1504;Dowmycin E;Eratrex;Erythrocin stearate;Erythromycin stearate (salt);Erythromycin steraric acid salt;Ethril;Ethril 250;Ethril 500;HSDB 4178;Meberyt;NCI-C55674;OE 7;Octadecanoic acid, compd. with erythromycin (1:1);Pfizer-E;Qidmycin;Stearic acid, compd. with erythromycin (1:1);UNII-LXW024X05M;Wyamycin S;Erythromycin octadecanoate (salt);Erythromycin, stearate (salt);octadecanoic acid - (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione (1:1) (non-preferred name);(2S,3R,4S,6R)-4-(dimethylamino)-2-{[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyl-2,10-dioxooxacyclotetradecan-6-yl]oxy}-6-methyltetrahydro-2H-pyran-3-yl octadecanoate (non-preferred name);

• CAS NO :

  643-22-1

• EC NO :

  211-396-1

• Molecular Formula :

  C₅₅H₁₀₁NO₁₄

• Molecular Weight :

  1000.3887

• Main Specifications :

• InChI :

  InChI=1/C55H101NO14/c1-15-17-18-19-20-21-22-23-24-25-26-27-28-29-30-31-43(57)68-47-41(56(12)13)32-36(4)65-52(47)70-50-38(6)46(69-44-34-54(10,64-14)49(60)40(8)66-44)39(7)51(61)67-42(16-2)55(11,63)48(59)37(5)45(58)35(3)33-53(50,9)62/h35-42,44,46-50,52,59-60,62-63H,15-34H2,1-14H3/t35-,36-,37+,38+,39-,40+,41+,42-,44+,46+,47-,48-,49+,50-,52+,53-,54-,55-/m1/s1

• Product description :

  The main product of the pharmaceuticals line is erythromycin, which Ercros produces at its factory in Aranjuez (Madrid). Ercros is the world's second largest manufacturer of erythromycin base, salts and derivatives, with an 11% share of the free market production.

  Erythromycin is a wide spectrum antibacterial antibiotic which is specially indicated in the treatment of respiratory and skin complaints.

  Ercros directly sell part of the erythromycin base it manufactures, but most of it is consumed at the same utility as a raw material going into the manufacture of erythromycin salts and derivatives.

• Molecular Structure :